Hedge funds have now sold chip stocks for four consecutive weeks as the broader AI trade comes under pressure, marking a sustained institutional exit from the sector's recent leaders. The persistent unwind raises the question of whether this is a tactical pause before re-entry or the beginning of a deeper de-rating for AI-exposed semis.
Hedge funds have now sold chip stocks for four consecutive weeks as the broader AI trade comes under pressure, marking a sustained institutional exit from the sector's recent leaders.
With hedge funds net-selling NVDA, AMD, and AVGO for four consecutive weeks, the question is whether institutional positioning has already cleared enough to set up a re-entry, or whether the AI valuation unwind has further to run.
A single positive hyperscaler AI capex update or a surprise NVDA guidance raise could reverse the fund flow trend rapidly, trapping any short; conversely, a broader AI spending slowdown narrative could extend the selling well beyond four weeks.
CoverageSource: Reuters · Published here MON, JUL 6 · 7:18 AM ET · the only report in this recordHow this is decided →
Hedge funds extended their selling of semiconductor stocks into a fourth straight week, according to Reuters, as the AI-driven rally that powered names like NVDA, AMD, and AVGO through much of 2024 faces renewed pressure. The four-week streak of net selling signals a sustained, not opportunistic, institutional reduction rather than a single-session risk-off flush.
NVDA remains the most consequential name in focus — revenues hit $215.9B in FY2026 (ended Jan 25), up 65.5% YoY, with a 71.1% gross margin and $4.90 diluted EPS that are genuinely extraordinary by any sector comparison. AMD ($34.6B rev, +34.3% YoY) and AVGO ($63.9B rev, +23.9% YoY) also carry strong fundamental profiles, yet all three are caught in the same institutional selling wave.
The tension here is classic: hedge fund positioning data lags price, meaning four weeks of selling could mean the 'smart money' exit is already largely complete and a re-entry window is forming — or it could mean the unwind has further to run as AI capex narratives get stress-tested against actual hyperscaler spend data.
What to watch: whether the selling is concentrated in NVDA (highest valuation multiple, most crowded trade) or rotating into AMD/AVGO as relative-value plays, and whether upcoming hyperscaler earnings commentary on AI capex arrests the outflow or accelerates it. A stabilization in fund flow data — particularly prime brokerage net positioning — is the cleaner catalyst signal than price action alone.
Four consecutive weeks of hedge fund selling is a meaningful positioning signal but carries no intrinsic directional edge on its own — it could mark capitulation or continuation. NVDA's fundamentals (65.5% revenue growth, 71.1% gross margin) are difficult to short on merit, but crowded-trade unwinds don't respect fundamentals in the short term. Without a known catalyst date or prime brokerage net-positioning data showing a clear extreme, the setup is genuinely two-sided.
The read above, as written. kept as written · closes shown from JUL 6 on
2-4 weeks, until next hyperscaler earnings cycle. Follow to be told when one lands.
Price context does not establish that the story caused the move.
NVDA's 65.5% YoY revenue growth and 71.1% gross margin argue that four weeks of positioning-driven selling is a technical flush, not a fundamental de-rating, and historically crowded-trade washouts in high-quality compounders have resolved to the upside.
Sustained four-week institutional selling in a sector still carrying elevated valuation multiples suggests the AI capex cycle may be entering a digestion phase, and AMD's comparatively thin 12.5% net margin leaves it exposed if multiple compression accelerates across the group.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
Reaction = the first close after the story against the close before it. Prior-session closes only; not a call.
Shares a name with this story — discovery, not a connection.
This page is kept as it was written on Jul 6. Later coverage joins it only when the company and catalyst evidence match, and what the stock did is shown from licensed end-of-day closes — never re-graded, never backdated. The judgment is yours.